High-dilution peroxyacid disinfectant formulations with persistent bacteriostatic coatings

Technology
Conceptual
University

A novel disinfectant platform using peroxyacid compounds (peracetic and performic acid) that achieve rapid germ-kill at high dilutions (1:200) across diverse organisms. Nontoxic additives like chitosans and surfactants create lasting bacteriostatic surface coatings, enabling effective water and surface disinfection with minimal chemical use.

Overview

This research program develops optimized peroxyacid-based disinfectant formulations capable of achieving greater than 3-log inactivation of bacteria, viruses, spores, and fungi within 10 minutes at dilutions as high as 1:200. The technology targets both aqueous disinfection (water and wastewater) and surface applications (hard surfaces and fabrics). A key innovation is the incorporation of nontoxic additives such as chitosans and surfactants that form persistent bacteriostatic coatings on treated surfaces without reducing the germ-kill performance of the active peroxyacid compounds. This dual-action approach delivers rapid disinfection while providing residual surface protection, addressing a critical gap in conventional disinfectants that lose efficacy once dry.

Technical specifications

Core active ingredients:

  • Peracetic acid and performic acid compounds
  • Effective at dilutions ranging from 1:100 to 1:1000
  • Functional across pH range of 5–10 and total organic carbon (TOC) levels of 0–100 mg/L

Performance targets:

  • Greater than 3-log inactivation within 10 minutes of contact time
  • Broad-spectrum efficacy against indicator bacteria (E. coli), viruses (MS2 and Phi6 bacteriophages), fungi (Candida albicans), and spores (Clostridium sporogenes)
  • Effective on both hard surfaces and soft (fabric) surfaces

Additive system:

  • Chitosan-based and surfactant-based nontoxic additives
  • Form persistent bacteriostatic coatings on treated surfaces
  • No compromise to primary germ-kill performance

Regulatory status: Peroxyacids already hold regulatory approval for many disinfection applications, supporting a streamlined commercialization pathway.

Technology readiness level

The technology is currently at proof-of-concept stage (TRL 3–4). Prior bench-scale screening and time-resolved batch disinfection trials over a two-year period have demonstrated promising inactivation performance at dilutions from 1:100 to 1:1000 in water, wastewater, and hard surface applications. A planned six-month proof-of-concept study will conduct high-throughput screening followed by batch experiments testing multiple dilutions (1:100, 1:300, 1:1000) against a panel of indicator organisms at 25 °C, with survival analysis at 1, 3, 10, and 30 minutes using standard culture methods. Further validation is needed to confirm additive coating persistence and performance under real-world conditions.


About University of North Carolina, Chapel Hill

UNC–Chapel Hill is a comprehensive public research university and the state’s flagship, pairing broad academic depth with a major academic health system. Industry partners access co‑located core facilities, sponsored research, and an on‑campus innovation hub that connects companies to faculty and advanced instrumentation. Integration with a major hospital system and statewide clinics enables patient access, clinical trials, and real‑world evidence collaborations. Minutes from Research Triangle Park, the university works within a dense corporate R&D ecosystem. Research is supported by strong competitive federal funding, including NIH and NSF, and a dedicated technology transfer office streamlines IP, licensing, MTAs, and startup formation.

Sign up to access the full partnering listing.
View the details of this partnering listing and connect directly with the teams behind promising technologies.
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.